Effects of 6-hydroxydopamine treatments on active avoidance responding: evidence for involvement of brain dopamine.
D000818:Animals; D001362:Avoidance Learning / Q000187:drug effects*; D001923:Brain Chemistry; D003891:Desipramine / Q000494:pharmacology; D004298:Dopamine / Q000032:analysis / Q000502:physiology*; D006892:Hydroxydopamines / Q000008:administration & dosage / Q000494:pharmacology*; D008124:Locomotion / Q000187:drug effects; D008297:Male; D008781:Methyltyrosines / Q000494:pharmacology; D009043:Motor Activity / Q000187:drug effects; D009638:Norepinephrine / Q000032:analysis; D010293:Pargyline / Q000494:pharmacology; D051381:Rats; D012110:Reserpine / Q000494:pharmacology; D012701:Serotonin / Q000032:analysis; D013997:Time Factors
D006892:Hydroxydopamines; D008781:Methyltyrosines; D012701:Serotonin; D012110:Reserpine; D010293:Pargyline; D003891:Desipramine; D004298:Dopamine; D009638:Norepinephrine